Dyslipidemia: Difference between revisions
No edit summary |
No edit summary |
||
| Line 18: | Line 18: | ||
== Reverse Cholesterol Transport == | == Reverse Cholesterol Transport == | ||
{{#ev:youtube|T-jkTGM1fWw}} | Reverse cholesterol transport is a mechanism by high-density lipoprotein that works as the atheroprotective effect, means protects from atherosclerosis formation .<ref>Poznyak AV, Kashirskikh DA, Sukhorukov VN, Kalmykov V, Omelchenko AV, Orekhov AN. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836120/ Cholesterol transport dysfunction and its involvement in atherogenesis]. International Journal of Molecular Sciences. 2022 Jan 25;23(3):1332. | ||
</ref>{{#ev:youtube|T-jkTGM1fWw}} | |||
== Hypoalphalipoproteinemia == | == Hypoalphalipoproteinemia == | ||
Revision as of 18:11, 22 December 2023
Original Editor - Rahma Ahmed Ahmed Bahbah
Top Contributors - Rahma Ahmed Ahmed Bahbah
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (22/12/2023)
Introduction[edit | edit source]
Dyslipidemia is characterized by an elevation of low-density lipoprotein cholesterol (LDL-C) and reduced serum high-density lipoprotein cholesterol (HDL-C) concentration.[1]
Reverse Cholesterol Transport[edit | edit source]
Reverse cholesterol transport is a mechanism by high-density lipoprotein that works as the atheroprotective effect, means protects from atherosclerosis formation .[2]
Hypoalphalipoproteinemia[edit | edit source]
Atherogenic Dyslipidemia[edit | edit source]
Lipid Disorders[edit | edit source]
There are 4 different lipid disorders:
- Dyslipidemia
- Hyperlipidemia
- Hypercholesterolemia
- Hypertriglyceridaemia
To know the difference, check this video
References[edit | edit source]
- ↑ Marques LR, Diniz TA, Antunes BM, Rossi FE, Caperuto EC, Lira FS, Gonçalves DC. Reverse cholesterol transport: molecular mechanisms and the non-medical approach to enhance HDL cholesterol. Frontiers in Physiology. 2018 May 15;9:526.
- ↑ Poznyak AV, Kashirskikh DA, Sukhorukov VN, Kalmykov V, Omelchenko AV, Orekhov AN. Cholesterol transport dysfunction and its involvement in atherogenesis. International Journal of Molecular Sciences. 2022 Jan 25;23(3):1332.
